Metraipolis › archive › dc_2f02113bad4d
Next-generation cancer vaccines: targeting cryptic and non-canonical antigens for precision immunotherapy — Europe PMC PMID:41018485
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41018485
- DOI
- 10.37349/etat.2025.1002338
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T18:17:26.325Z
- SHA-256 of the archived text
dc48a3cde770458a101248e2d9b4fd1850cacd3795bdbffcd73b94e5c3c9dec6- Stable URL of this page
https://metraipolis.com/documento/dc_2f02113bad4d
How to cite
Next-generation cancer vaccines: targeting cryptic and non-canonical antigens for precision immunotherapy — Europe PMC PMID:41018485 — Europe PMC (en), https://europepmc.org/article/MED/41018485 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2f02113bad4d (Metraipolis archive dc_2f02113bad4d, sha256 dc48a3cde770458a101248e2d9b4fd1850cacd3795bdbffcd73b94e5c3c9dec6)
BibTeX
@misc{dc2f02113bad4d,
title = {Next-generation cancer vaccines: targeting cryptic and non-canonical antigens for precision immunotherapy — Europe PMC PMID:41018485},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41018485},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2f02113bad4d; sha256 dc48a3cde770458a101248e2d9b4fd1850cacd3795bdbffcd73b94e5c3c9dec6},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41018485. Agents can read the archived copy with the MCP tool read_document.